Skovdal, Morten
Clausen, Camilla Lysemose
Magoge-Mandizvidza, Phyllis
Dzamatira, Freedom
Maswera, Rufurwokuda
Nyamwanza, Rangarirayi Primrose
Nyamukapa, Constance
Thomas, Ranjeeta
Gregson, Simon
Funding for this research was provided by:
National Institutes of Health (R01MH114562–01)
Bill and Melinda Gates Foundation (OPP1161471)
Article History
Received: 11 November 2021
Accepted: 11 August 2022
First Online: 16 August 2022
Declarations
:
: The study obtained ethical approvals from the Medical Research Council of Zimbabwe (REF: MRCZ/A/2243), the institutional review board of the Biomedical Research and Training Institute in Zimbabwe (REF: AP140/2017), and the Imperial College London Research Ethics Committee (REF: 17IC4160). All methods and procedures were performed in accordance with the relevant guidelines and regulations set forth by the aforementioned review boards. Written informed consent was obtained from all participants with the agreement that their identities would be kept confidential.
: Not applicable.
: SG declares shareholdings in pharmaceutical companies [GSK and Astra Zeneca]; all other authors have no competing interests to declare.